Forward Look

Study findings suggest patient screening has been too narrow.

by Sharon Tregaskis

Survivor Profile

Rabbi Ben David was comfortable in his role of helping those in need, but he had to rely on others after his lymphoma diagnosis. The marathon runner has returned to an active life one step at a time.

by Lindsey Konkel

Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.

by Kendall K. Morgan

Forward Look

Studies aim to identify when screening is beneficial.

by Sue Rochman

From the Editor-in-Chief

Hepatitis C infection, obesity and alcohol can contribute to more cases of liver cancer.

by William G. Nelson, MD, PhD

Forward Look

Similarities between cancers create path for studying new treatments.

by Cameron Walker

Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.

by Anna Azvolinsky

Patients diagnosed with low-risk prostate cancer are increasingly opting against immediate surgery or radiation in favor of regularly monitoring their disease.

by Jon Kelvey

A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.

by Bradley Jones

A study investigates how people who have been diagnosed with cancer feel about being called survivors.

by Jen Tota McGivney